Literature DB >> 17937928

Genetic inactivation of GIP signaling reverses aging-associated insulin resistance through body composition changes.

Chizumi Yamada1, Yuichiro Yamada, Katsushi Tsukiyama, Kotaro Yamada, Shunsuke Yamane, Norio Harada, Kazumasa Miyawaki, Yutaka Seino, Nobuya Inagaki.   

Abstract

Aging is associated with increased fat mass and decreased lean mass, which is strongly associated with the development of insulin resistance. Gastric inhibitory polypeptide (GIP) is known to promote efficient storage of ingested nutrients into adipose tissue; we examined aging-associated changes in body composition using 10-week-old and 50-week-old wild-type (WT) and GIP receptor knockout (Gipr-/-) mice on a normal diet, which show no difference in body weight. We found that Gipr-/- mice showed significantly reduced fat mass without reduction of lean mass or food intake, while WT mice showed increased fat mass and decreased lean mass associated with aging. Moreover, aged Gipr-/- mice showed improved insulin sensitivity, which is associated with amelioration in glucose tolerance, higher plasma adiponectin levels, and increased spontaneous physical activity. We therefore conclude that genetic inactivation of GIP signaling can prevent the development of aging-associated insulin resistance through body composition changes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17937928     DOI: 10.1016/j.bbrc.2007.09.128

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Glucose-dependent insulinotropic polypeptide directly induces glucose transport in rat skeletal muscle.

Authors:  Laelie A Snook; Emery M Nelson; David J Dyck; David C Wright; Graham P Holloway
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-06-03       Impact factor: 3.619

2.  Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance.

Authors:  Julio E Ayala; Deanna P Bracy; Freyja D James; Melissa A Burmeister; David H Wasserman; Daniel J Drucker
Journal:  Endocrinology       Date:  2010-08-04       Impact factor: 4.736

3.  Transgenic rescue of adipocyte glucose-dependent insulinotropic polypeptide receptor expression restores high fat diet-induced body weight gain.

Authors:  Randi Ugleholdt; Jens Pedersen; Maria Rosaria Bassi; Ernst-Martin Füchtbauer; Signe Marie Jørgensen; Hanne-Louise Kissow; Nikolaj Nytofte; Steen Seier Poulsen; Mette Marie Rosenkilde; Yutaka Seino; Peter Thams; Peter Johannes Holst; Jens Juul Holst
Journal:  J Biol Chem       Date:  2011-10-25       Impact factor: 5.157

4.  The glucose-dependent insulinotropic polypeptide and glucose-stimulated insulin response to exercise training and diet in obesity.

Authors:  Karen R Kelly; Latina M Brooks; Thomas P J Solomon; Sangeeta R Kashyap; Valerie B O'Leary; John P Kirwan
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-04-07       Impact factor: 4.310

Review 5.  Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications.

Authors:  N Irwin; P R Flatt
Journal:  Diabetologia       Date:  2009-06-17       Impact factor: 10.122

6.  Metabolic effects of diets differing in glycaemic index depend on age and endogenous glucose-dependent insulinotrophic polypeptide in mice.

Authors:  F Isken; M O Weickert; M H Tschöp; R Nogueiras; M Möhlig; A Abdelrahman; S Klaus; B Thorens; A F Pfeiffer
Journal:  Diabetologia       Date:  2009-07-31       Impact factor: 10.122

7.  WNT/beta-catenin increases the production of incretins by entero-endocrine cells.

Authors:  J M García-Martínez; A Chocarro-Calvo; C M Moya; C García-Jiménez
Journal:  Diabetologia       Date:  2009-07-07       Impact factor: 10.122

8.  Tissue-specific effects of bariatric surgery including mitochondrial function.

Authors:  Simon N Dankel; Vidar Staalesen; Bodil Bjørndal; Rolf K Berge; Gunnar Mellgren; Lena Burri
Journal:  J Obes       Date:  2011-01-12

9.  Gastric inhibitory polypeptide receptor: association analyses for obesity of several polymorphisms in large study groups.

Authors:  Carla I G Vogel; André Scherag; Günter Brönner; Thuy T Nguyen; Hai-Jun Wang; Harald Grallert; Alexa Bornhorst; Dieter Rosskopf; Henry Völzke; Thomas Reinehr; Winfried Rief; Thomas Illig; H-Erich Wichmann; Helmut Schäfer; Johannes Hebebrand; Anke Hinney
Journal:  BMC Med Genet       Date:  2009-03-02       Impact factor: 2.103

10.  Link between GIP and osteopontin in adipose tissue and insulin resistance.

Authors:  Emma Ahlqvist; Peter Osmark; Tiina Kuulasmaa; Kasper Pilgaard; Bilal Omar; Charlotte Brøns; Olga Kotova; Anna V Zetterqvist; Alena Stancáková; Anna Jonsson; Ola Hansson; Johanna Kuusisto; Timothy J Kieffer; Tiinamaija Tuomi; Bo Isomaa; Sten Madsbad; Maria F Gomez; Pernille Poulsen; Markku Laakso; Eva Degerman; Jussi Pihlajamäki; Nils Wierup; Allan Vaag; Leif Groop; Valeriya Lyssenko
Journal:  Diabetes       Date:  2013-01-24       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.